Amoxibactin vet Tafla 250 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

amoxibactin vet tafla 250 mg

le vet beheer b.v. - amoxicillinum tríhýdrat - tafla - 250 mg

Amoxibactin vet Tafla 50 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

amoxibactin vet tafla 50 mg

le vet beheer b.v. - amoxicillinum tríhýdrat - tafla - 50 mg

Clavubactin vet. (Clavoral) Tafla 250/62,5 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

clavubactin vet. (clavoral) tafla 250/62,5 mg

le vet b.v.* - amoxicillinum tríhýdrat; acidum clavulanicum kalíum - tafla - 250/62,5 mg

Clavubactin vet. (Clavoral) Tafla 50/12,5 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

clavubactin vet. (clavoral) tafla 50/12,5 mg

le vet b.v.* - amoxicillinum tríhýdrat; acidum clavulanicum kalíum - tafla - 50/12,5 mg

Eficur vet. Stungulyf, dreifa 50 mg/ml Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

eficur vet. stungulyf, dreifa 50 mg/ml

laboratorios hipra s.a.* - ceftiofurum hýdróklóríð - stungulyf, dreifa - 50 mg/ml

Spectrabactin Vet Tafla 200 mg/50 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

spectrabactin vet tafla 200 mg/50 mg

dechra regulatory b.v. - amoxicillinum tríhýdrat; acidum clavulanicum kalíum - tafla - 200 mg/50 mg

Spectrabactin Vet Tafla 40 mg/10 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

spectrabactin vet tafla 40 mg/10 mg

dechra regulatory b.v. - amoxicillinum tríhýdrat; acidum clavulanicum kalíum - tafla - 40 mg/10 mg

Vetrimoxin L.A. Stungulyf, dreifa 150 mg/ml Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

vetrimoxin l.a. stungulyf, dreifa 150 mg/ml

ceva santé animale* - amoxicillinum tríhýdrat - stungulyf, dreifa - 150 mg/ml

Moviprep Mixtúruduft, lausn Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

moviprep mixtúruduft, lausn

norgine b.v. - macrogol 3350; natrii sulfas; natrii chloridum; kalii chloridum; acidum ascorbicum inn; natrii ascorbas inn - mixtúruduft, lausn

Aubagio Evrópusambandið - íslenska - EMA (European Medicines Agency)

aubagio

sanofi winthrop industrie - teriflunomide - margvísleg sclerosis - valdar ónæmisbælandi lyf - aubagio is indicated for the treatment of adult patients and paediatric patients aged 10 years and older with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 for important information on the population for which efficacy has been established).